Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial

PURPOSE: This trial aimed to assess the efficacy and safety of the paclitaxel plus fluorouracil regimen versus the cisplatin plus fluorouracil regimen in definitive concurrent chemoradiotherapy (dCRT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). PATIENTS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yun, Ye, Jinjun, Zhu, Zhengfei, Zhao, Weixin, Zhou, Jialiang, Wu, Chaoyang, Tang, Huarong, Fan, Min, Li, Ling, Lin, Qin, Xia, Yi, Li, Yunhai, Li, Jiancheng, Jia, Huixun, Lu, Saiquan, Zhang, Zhen, Zhao, Kuaile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
RAPID COMMUNICATION
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638596/
https://www.ncbi.nlm.nih.gov/pubmed/30920880
http://dx.doi.org/10.1200/JCO.18.02122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6638596/
https://www.ncbi.nlm.nih.gov/pubmed/30920880
http://dx.doi.org/10.1200/JCO.18.02122

Ejemplares similares